AU2003239243A1 - 5-ring heterocycles used as antiviral agents - Google Patents

5-ring heterocycles used as antiviral agents

Info

Publication number
AU2003239243A1
AU2003239243A1 AU2003239243A AU2003239243A AU2003239243A1 AU 2003239243 A1 AU2003239243 A1 AU 2003239243A1 AU 2003239243 A AU2003239243 A AU 2003239243A AU 2003239243 A AU2003239243 A AU 2003239243A AU 2003239243 A1 AU2003239243 A1 AU 2003239243A1
Authority
AU
Australia
Prior art keywords
antiviral agents
ring heterocycles
heterocycles used
ring
antiviral
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003239243A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer Healthcare AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Healthcare AG filed Critical Bayer Healthcare AG
Publication of AU2003239243A1 publication Critical patent/AU2003239243A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D249/12—Oxygen or sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/18—One oxygen or sulfur atom
    • C07D231/20—One oxygen atom attached in position 3 or 5
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2003239243A 2002-01-28 2003-01-16 5-ring heterocycles used as antiviral agents Abandoned AU2003239243A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10203086A DE10203086A1 (en) 2002-01-28 2002-01-28 5-ring heterocycles
DE10203086.3 2002-01-28
PCT/EP2003/000376 WO2003064394A1 (en) 2002-01-28 2003-01-16 5-ring heterocycles used as antiviral agents

Publications (1)

Publication Number Publication Date
AU2003239243A1 true AU2003239243A1 (en) 2003-09-02

Family

ID=7713161

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003239243A Abandoned AU2003239243A1 (en) 2002-01-28 2003-01-16 5-ring heterocycles used as antiviral agents

Country Status (6)

Country Link
EP (1) EP1472229A1 (en)
JP (1) JP2005521669A (en)
AU (1) AU2003239243A1 (en)
CA (1) CA2474456A1 (en)
DE (1) DE10203086A1 (en)
WO (1) WO2003064394A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0515944B1 (en) * 2004-09-29 2021-11-09 Bayer Healthcare Llc PROCESS FOR THE PREPARATION OF 4-{4-[({[4-CHLORINE-3-(TRIFLUOROMETHYL)PHEN]AMINO}CARBONYL) AMINO]PHENOXY}NMETHYLPYRIDINE-2-CARBOXAMIDE
EP2958897B1 (en) 2013-02-19 2019-01-09 Senomyx, Inc. Compounds useful as modulators of trpm8

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES482789A0 (en) * 1978-08-25 1980-12-01 Thomae Gmbh Dr K PROCEDURE FOR THE PREPARATION OF NEW BENZHIMIDAZOLES REPLACED IN POSITION 5 OR 6 WITH A PYRIDAZINONE RING
EA000828B1 (en) * 1995-12-14 2000-04-24 Мерк Энд Ко., Инк. Antagonists of gonadotropin releasing hormone
ES2155817T3 (en) * 1997-12-22 2007-06-16 Bayer Pharmaceuticals Corp. INHIBITION OF THE ACTIVITY OF QUINASA P38 USING HETEROCICLIC UREAS REPLACED WITH ARILO AND HETEROARILO.

Also Published As

Publication number Publication date
CA2474456A1 (en) 2003-08-07
WO2003064394A8 (en) 2003-12-24
WO2003064394A1 (en) 2003-08-07
DE10203086A1 (en) 2003-07-31
EP1472229A1 (en) 2004-11-03
JP2005521669A (en) 2005-07-21

Similar Documents

Publication Publication Date Title
AU2002344061A1 (en) Robot
AU2003294717A1 (en) Herbicidal composition
AU2003274022A1 (en) 3-heterocyclylpyridine derivatives useful as herbicides
IL164621A0 (en) Pestidical heterocycles
GB0211257D0 (en) Novel heterocycles
AU2002335728A1 (en) Heterocycle substituted purines as antiproliferative agents
AU2003211385A1 (en) Azole compounds
AU2003273989A1 (en) Quinazolinone derivatives useful as anti-hyperalgesic agents
AU2003231947A1 (en) Defensins: use as antiviral agents
AU2003254059A1 (en) Antimisting agents
AU2003229265A1 (en) Rope-guided hoisting body
AU2003290818A1 (en) Topoisomerase-targeting agents
AU2003280578A1 (en) Heterocyclic compounds
AU2003244148A1 (en) Antifungal agents for external use
GB0209989D0 (en) Novel heterocycles
AU2002952559A0 (en) New use
AU2003239243A1 (en) 5-ring heterocycles used as antiviral agents
AU2003269950A1 (en) Heteroaryl-ethanolamine derivatives as antiviral agents
AU2003273169A1 (en) 7-phenylsulfonyl-tetrahydro-3-benzazepine derivatives as antipsychotic agents
AU2002953019A0 (en) Azole derivatives
AU2003304151A1 (en) Heteroaryl-ethanolamine derivatives as antiviral agents
AU2003205994A1 (en) Worktable
AU2003265385A1 (en) Aryl-ethanolamine derivatives as antiviral agents
AU2002247888A1 (en) The management of work forces
AU2003219091A1 (en) Working platform

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase